KELSEY RICHMOND: Open Payments
NPI 1093238479 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$947 in 36 payments from 17 companies in 2025. Trend: 2023 $748 · 2024 $859 · 2025 $947
Food & beverage: $947
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $161 |
| Calliditas Therapeutics US Inc. | 5 | $135 |
| CORDIS US CORP. | 1 | $125 |
| Travere Therapeutics, Inc. | 3 | $63 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Fresenius USA Marketing, Inc. | 3 | $58 |
| Apellis Pharmaceuticals, Inc. | 2 | $54 |
| Recor Medical Inc | 2 | $46 |
| Alpha Cognition USA, Inc. | 1 | $46 |
| Amgen Inc. | 2 | $36 |
Products named: JYNARQUE, TARPEYO, S.M.A.R.T. CONTROL, VELPHORO, Empaveli, Paradise Ultrasound Renal Denervation System, Zunveyl, FARXIGA.
Industry payments across SC — which companies pay providers there.
